Multiplexed identification, quantification and genotyping of infectious agents using a semiconductor biochip.

Area of Science:

• Biotechnology
• Molecular Diagnostics
• Antimicrobial Resistance

Background:

• Antimicrobial resistance (AMR) poses a significant global health threat, potentially leading to a post-antibiotic era.
• Rapid and accurate diagnostics are crucial to reduce antibiotic overuse and manage infections effectively.

Purpose of the Study:

• To develop an integrated, miniaturized molecular diagnostics system for rapid pathogen identification and drug-resistance mutation detection.
• To enable point-of-care testing for timely clinical decision-making.

Main Methods:

• Development of a fully integrated, miniaturized semiconductor biochip.
• Implementation of closed-tube multiplex nucleic acid amplification and sequence analysis.
• High-throughput analysis of up to 1,000 sequences simultaneously in under 2 hours.

Main Results:

• Accurate detection and quantification of multiple DNA and RNA respiratory viruses in clinical samples, with results matching a commercial test.
• Identification of 54 drug-resistance-associated mutations across six genes in Mycobacterium tuberculosis.
• Confirmation of identified mutations through next-generation sequencing.

Conclusions:

• The developed biochip system offers a rapid, comprehensive solution for molecular diagnostics at the point of care.
• This technology has the potential to significantly impact the management of infectious diseases and combat antimicrobial resistance.